<DOC>
	<DOCNO>NCT02474550</DOCNO>
	<brief_summary>This study design review clincal outcome Diffuse Large B Cell Lymphoma ( DLBCL ) treat R-CHOP chemotherapy era pegylated-filgrastim . The investigator prospectively collect clinical data treatment outcome patient DLBCL use prophylactic pegylated-filgrastim .</brief_summary>
	<brief_title>Multicenter Prospective Registry Study Diffuse Large B Cell Lymphoma</brief_title>
	<detailed_description>- Newly diagnose DLBCL patient treat R-CHOP chemotherapy - Prphylactic peg-filgrastim day chemotherapy</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Febrile Neutropenia</mesh_term>
	<criteria>19 old newly diagnose DLBCL RCHOP chemotherapy offer informed consent subtype NHL concomitant cancer previous chemotherapy radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>diffuse large b cell lymphoma</keyword>
	<keyword>peg-filgrastim</keyword>
	<keyword>febrile neutropenia</keyword>
</DOC>